AstraZeneca Group News

Investors who are bullish on the generic drug industry may consider implementing a 130 / 30 global pharma investing strategy through equal-weight short positions for the six brand drug companies outlined below with 30% of their assets while investing 130% of assets in long positions among generic drug makers.

AstraZeneca has launched a blog - AZ Health Connections - and the critics don't like it.

Targacept Inc. posted its first quarterly profit in nearly three years yesterday, bolstered in large part by a $10 million milestone payment by AstraZeneca PLC.

Four area companies are hoping to reap financing from the Mid-Atlantic Bio conference in Washington.

An AstraZeneca executive warned in an internal email that the company's data did not show its antipsychotic drug Seroquel was superior to an older drug, Haldol , but the company promoted that notion anyway, according to documents in a lawsuit filed against the company.

Drugmaker AstraZeneca P.L.C. said yesterday that it had set aside $520 million as part of a tentative agreement to resolve an investigation by federal prosecutors in Philadelphia into the company's marketing practices.

I last recommended that Fools take a look at consumer-staples company Clorox back in June.

Quintiles today announced that it has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZenecaa s clinical pharmacology studies across multiple therapy areas and around the globe.

17-19 in Boston, MA. This year's list will offer a Top 10 in each of four therapeutic areas: cardiovascular/metabolic, oncology, neuroscience and inflammatory/autoimmune. Past Windhover top 10 candidates signed a total potential value of $17 billion US in acquisitions and alliances.

LONDON: AstraZeneca increased its full-year outlook for the second quarter in a row yesterday as earnings jumped 28 percent, beating forecasts, helped by earlier-than-expected revenues from its swine flu vaccine.

The British Journal of Psychiatry 195: S29-S36. doi: 10.1192/bjp.195.52.s29 © 2009 The Royal College of Psychiatrists REVIEW ARTICLES Second-generation antipsychotic long-acting injections: systematic review W. Wolfgang Fleischhacker, Professor of Psychiatry Medical University Innsbruck, Department of Psychiatry and Psychotherapy, Anichstrasse ...

The European Medicines Agency has been formally notified by AstraZeneca of its decision to withdraw its application for a centralised marketing authorisation for the medicine Zactima , 100 mg film-coated tablets.

The focus of AstraZeneca 's earnings report illustrates the nature of polar opposites with one-time gains and new drugs.

The pharmaceutical company AstraZeneca said Thursday that it had reached a $520 million agreement to settle two federal investigations and two whistle-blower lawsuits over the sale and marketing of its blockbuster psychiatric drug Seroquel.

WAM Dubai, 29th Oct. 2009 : Between 30 to 40 per cent of mental illnesses in the UAE are schizophrenia-related, while another 30 to 40 per cent belong to the bipolar disorder category.

A swine flu vaccine windfall worth $152m contributed to a leap in third quarter profits at UK drug giant AstraZeneca, the group revealed today.

Pharmaceutical company AstraZeneca PLC has reported an 22 percent rise in third quarter net profit, boosted by initial sales of its swine flu vaccine and delayed entry of generic drug competition in the United States.

POZEN Inc. , today announced results for the third quarter ended September 30, 2009.

AstraZeneca PLC said Wednesday it has withdrawn applications for regulatory approval for its lung cancer drug Zactima following disappointing trial results.

Cubist Pharmaceuticals Inc. filed Quarterly Report for the period ended 2009-09-30. Cubist Pharmaceuticals Inc.